Monday 19 October 2026
Export PBLS’s income statement to Excel — free account
Parabilis Medicines, Inc.
PBLS
Insiders bought in the last twelve months.
22.75
2.43
−9.65%
Follow PBLS
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+1 more TTM period Free account |
|
| 0.00% | — | — | — | ||
ROIC |
0.00% | 0.00% | 0.00% | — | |
Return on Tangible Assets |
(21.60%) | 0.00% | 0.00% | — | |
Free Cash Flow per Share |
(4.12) | 0.00 | — | 0.00 | |
Free Cash Flow |
(119.14) | — | — | — | |
Capital Expenditures |
(1.07) | — | — | — | |
| Other line items | |||||
Cash ROIC |
(5.48%) | 0.00% | 0.00% | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | — | — | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Interest Coverage |
(135.00) | — | — | — | |
Operating CF/Net income |
0.51 | — | — | — | |
Depreciation/Fixed assets |
0.41 | 0.00 | 0.00 | — | |
Capex/Depreciation |
(0.39) | — | — | — | |
Revenue per Share |
0.00 | 0.00 | — | 0.00 | |
Operating CF per Share |
(4.08) | 0.00 | — | 0.00 | |
Capex per Share |
(0.04) | 0.00 | — | 0.00 | |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates · fundamentals updated 30 Sep 2026